Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Salivary glands have been proposed as a tissue target site for gene therapy, especially in the area of vaccination by gene transfer. We demonstrate gene delivery in a non-human primate model utilizing retrograde parotid infusion.
Salivary glands are an attractive tissue target for gene therapy with promising results already leading to human trials. They are inherently capable of secreting proteins into the bloodstream and are easily accessible, making them potentially superior tissue sites for replacement hormone production or vaccination by gene transfer. Suggested methods for gene delivery include transcutaneous injection and retrograde infusion through salivary ducts. We demonstrate how to perform Retrograde Salivary Gland Infusion (RSGI) in non-human primates. We describe the important anatomic landmarks including identification of the parotid papilla, an atraumatic method of cannulating and sealing Stensen's Duct utilizing basic dental tools, polyethylene tubing, and cyanoacrylate, and the appropriate rate of infusion. While this is the least traumatic method of delivery, the method is still limited by the volume able to be delivered (<0.5 mL) and the potential for trauma to the duct and gland. We demonstrate using fluoroscopy that an infusate can be fully delivered into the gland, and further demonstrate by immunohistochemistry the transduction of a typical vector and expression of the delivered gene.
While salivary glands are well known for their exocrine production of saliva, researchers have long recognized their ability to secrete proteins directly into the bloodstream1, making them a potential target for gene therapy for systemic administration, such as replacement hormones or antibody production. In fact, salivary glands offer several advantages over other tissue targets, such as the inherent ability to produce proteins for secretion (a property muscles lack), heavy encapsulation that can limit vector diffusion, and well-differentiated tissue providing stability for non-integrating vectors. Furthermore, in the event of a serious adverse event, salivary glands are not critical for life and can be surgically removed. While not immediately intuitive, parotid glands are also easily accessible from the mouth through their main excretory duct, Stensen's Duct2.
Given the advantages of salivary tissue for gene therapy, there is increasing interest in exploring this tissue target. Numerous studies have already been performed in rodent, canine, and non-human primate models and at least one human clinical trial is underway3,4,5. To further explore and develop the utility of this tissue target for gene therapy purposes, more non-human primate studies will need to be performed. This paper describes a method for accessing the parotid glands through Stensen's Duct to deliver a vectored gene for transduction in the non-human primate model. To visibly demonstrate the delivery of the infusate and the anatomy of the duct as it enters the gland, fluoroscopy using radiocontrast was performed. To demonstrate successful transduction of a vector, an Adenovirus serotype 5 (Ad5) vectored egfp gene was used. Ad5 is a well-described vector capable of transducing salivary tissue. Although it is too immunogenic for ultimate clinical use, an Ad5 vector was chosen for this demonstration study to assure efficient transduction. Evaluating Enhanced Green Fluorescent Protein (EGFP) production is a well-described method to demonstrate successful transcription and translation of a vectored gene following transduction and was done here.
All procedures were performed at Wake Forest School of Medicine Clarkson Campus for animal studies. The Institutional Animal Care and Use Committee (IACUC) was consulted for ethical considerations and details of the procedures was submitted for review. Wake Forest IACUC approved our study protocol and all procedures were done under IACUC approved protocol #A17-147.
1. Preparing the infusion device
2. Preparing the animal
NOTE: Cynomolgus macaques were used for the video demonstration. The anatomy of other non-human and human primates is very similar, and the protocol should be translatable to other species.
3. Performing the procedure
4. Post-procedural care
Successful procedure, transduction and transcription
Figure 1 shows the parotid papilla adjacent to the 2nd molar on the posterior superior cheek. The image also shows the correct placement of the mouth brace, one rubber end on the hard palate and the other rubber end on the ipsilateral canine. Figure 2 shows an image taken after successful cannulation of the parotid papilla at the 2 cm mark on the PET10. Fi...
Here we describe a protocol of retrograde infusion into the parotid gland through Stensen's Duct. The methodology described offers guidance that can potentially be used by researchers exploring the utility of salivary tissue as a site for gene therapy and other applications.
There are multiple critical steps to ensure the success of the procedure. First and foremost, all the procedural steps should be completed gently. Forceful bracing of the mouth could result in mandibular subluxation. F...
The authors have nothing to disclose.
The authors want to thank Mr. Cagney Gentry for his audiovisual support in filming the procedure. We also want to acknowledge the Hefner VA medical center for academic support in pursuit of this project.
Name | Company | Catalog Number | Comments |
500 µL U100 syringes with 30-gauge needles | Becton Dickinson | 328466 | fixed needle for less waste |
Adhesive (e.g., Ethicon Dermabond) | Various | Cyanoacrylate adhesive to seal and keep the tubing in the duct during infusion. | |
Atropine injectable solution | Patterson Veterinary | 07 869-6061 | Atropine inj. 0.54 mg/mL |
BD Ultra-Fine Insulin Syringes 30G | Walmart | N/A | Avilable in 0.5 mL and 1.0 mL sizes. |
Cyanoacrylate (medical glue) | Ethicon | DNX12 | Dermabond topical skin adhesive |
Dental loops with light | Amazon (DDP) | B012M3IV80 | Used to enhance visualization of Stensen's duct papilla |
Infant Lacrimal Dilator | Surgipro | SPOI-137 | |
Ketamine injectable solution | Patterson Veterinary | 07-803-6637 | Ketaset inj. 100 mg/mL |
Lacrimal Dilator | Surgipro | SPOI-132 | Used to dialate the Stensen's duct. |
Midazolam injectable solution | Patterson Veterinary | 07 890-6698 | Midazolam inj. 5mg/mL |
Pair of scissors | Amazon (DDP) | N/A | Used to cut PET10 tube |
Polyethylene Tubing (PE-10) | Scientific Comodities, Inc | BB31695-PE/1 | Tubing connecting the 30G syringe and inserted into the duct. |
Q-tips | Walmart | N/A | Used to spread cyanoacrylate on the cheek |
Size 10 Polyethylene Tube (PET 10) | Scientific Commodities | BB31695-PE/1 | low density polyethylene tubing |
Small Animal Mouth Opener | Amazon (DDP) | B01F3LVJXC | Used to keep the animal's mouth open. |
Tweezers | Amazon (DDP) | N/A | Used to insert PET10 tube into Stenson's duct |
Zinc Chloride | Sigma-Aldrich | 7646-86-7 | Included in plasmid DNA infusates |
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone